Skip to main content
TipRanks
Go Ultimate75% OFF

Cardiol Therapeutics (CRDL) Stock Statistics & Valuation Metrics

645 Followers

Total Valuation

Cardiol Therapeutics has a market cap or net worth of $111.22M. The enterprise value is $250.60M.

Market Cap
$111.22M
Enterprise Value
$250.60M

Share Statistics

Cardiol Therapeutics has 127,688,400 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
127,688,400
Owned by Insiders
1.07%
Owned by Institutions
24.75%

Financial Efficiency

Cardiol Therapeutics’s return on equity (ROE) is -1.89 and return on invested capital (ROIC) is -190.61%.

Return on Equity (ROE)
-1.89
Return on Assets (ROA)
-1.43
Return on Invested Capital (ROIC)
-190.61%
Return on Capital Employed (ROCE)
-1.91
Revenue Per Employee
0
Profits Per Employee
-1.88M
Employee Count
18
Asset Turnover
0.00
Inventory Turnover
0.00

Valuation Ratios

The current PE Ratio of Cardiol Therapeutics is -3.65. Cardiol Therapeutics’s PEG ratio is -0.15.

PE Ratio
-3.65
PS Ratio
0.00
PB Ratio
5.22
Price to FCF
-6.76
Price to Operating Cash Flow
-6.64
PEG Ratio
-0.15

Income Statement

In the last 12 months, Cardiol Therapeutics had revenue of 0 and earned -33.82M in profits. Earnings per share was -0.39.

Revenue
0
Gross Profit
0
Operating Income
-34.32M
Pretax Income
-33.82M
Net Income
-33.82M
EBITDA
-34.21M
Earnings Per Share (EPS)
-0.39

Cash Flow

In the last 12 months, operating cash flow was -21.70M and capital expenditures -78,318, giving a free cash flow of -21.78M billion.

Operating Cash Flow
-21.70M
Free Cash Flow
-21.78M
Free Cash Flow per Share
-0.18

Dividends & Yields

Cardiol Therapeutics pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share
―
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
-14.79%
Earnings Yield
-26.00%

Stock Price Statistics

Beta
1.36
52-Week Price Change
-10.67%
50-Day Moving Average
1.34
200-Day Moving Average
1.31
Relative Strength Index (RSI)
25.25
Average Volume (3m)
1.20M

Important Dates

Cardiol Therapeutics upcoming earnings date is Apr 05, 2027, TBA (Not Confirmed).

Last Earnings Date
Nov 12, 2026
Next Earnings Date
Apr 05, 2027
Ex-Dividend Date
―

Financial Position

Cardiol Therapeutics as a current ratio of 4.16, with Debt / Equity ratio of 0.70%

Current Ratio
4.16
Quick Ratio
4.16
Debt to Market Cap
0.00
Net Debt to EBITDA
0.62
Interest Coverage Ratio
0.00

Taxes

In the past 12 months, Cardiol Therapeutics has paid 0 in taxes.

Income Tax
0
Effective Tax Rate
0.00

Enterprise Valuation

Cardiol Therapeutics EV to EBITDA ratio is -3.33, with an EV/FCF ratio of -5.42.

EV to Sales
0.00
EV to EBITDA
-3.33
EV to Free Cash Flow
-5.42
EV to Operating Cash Flow
-5.44

Balance Sheet

Cardiol Therapeutics has $29.23M in cash and marketable securities with $97.27K in debt, giving a net cash position of $29.13M billion.

Cash & Marketable Securities
$29.23M
Total Debt
$97.27K
Net Cash
$29.13M
Net Cash Per Share
$0.23
Tangible Book Value Per Share
$0.23

Margins

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

Gross Margin
0.00%
Operating Margin
0.00%
Pretax Margin
0.00%
Net Profit Margin
0.00%
EBITDA Margin
0.00%
EBIT Margin
0.00%

Analyst Forecast

The average price target for Cardiol Therapeutics is $10.00, which is 11.43% higher than the current price. The consensus rating is Strong Buy

Price Target
$10.00
Price Target Upside
1060.09% Upside
Analyst Consensus
Strong Buy
Analyst Count
3
Revenue Growth Forecast
―
EPS Growth Forecast
19.01%

Scores

Smart Score
4
AI Score
―